Santos will examine compliance strategies for the market research community and highlight how increasing competition, fast-changing technologies, marketing and medical pressures, contradictory legislation and media scrutiny are affecting market research.
New York, New York (PRWEB) March 05, 2013
Kantar Health, a leading global healthcare advisory firm, today announced that its global compliance director, Jessica Santos, Ph.D., will present at the Pharmaceutical Marketing Research Group (PMRG) Annual National Conference on March 12, 2013 in National Harbor, Maryland.
In her presentation ― “With Compliance Restrictions Increasing, What Does the Future Hold for Market Research?” ― Santos will examine compliance strategies for the market research community and highlight how increasing competition, fast-changing technologies, marketing and medical pressures, contradictory legislation and media scrutiny are affecting market research and client requirements.
She will discuss:
- Finding the balance between the ethical collection of market research data and the freedom to provide valuable insight for evidence-based decision making
- Research concepts that clients can use in the current environment to bridge medical and marketing
- How manufacturers can develop appropriate internal guidelines that comply with local and international laws without sacrificing valuable insights
Kantar Health is a Silver Sponsor of the 2013 PMRG Annual National Conference. More information on this event can be found at https://www.pmrg.org/EventsWebinars/2013AnnualNationalConference/tabid/736/Default.aspx.
About Kantar Health
Kantar Health is a leading global healthcare advisory firm and trusted advisor to the world’s largest pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and marketing expertise to help clients launch products and differentiate their brands in the marketplace.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.